MainBoardListed
Tatva Chintan Pharma Chem Limited
Company websiteTatva Chintan Pharma Chem Limited seeks to raise ₹46,16,804 crore — fresh issue ₹20,77,562 crore, OFS ₹25,39,242 crore. Total shares offered: 13.
Subscribe between 16-07-2021 and 20-07-2021. Allotment is expected on 26-07-2021, with listing on 29-07-2021. Action tip: if you’re unsure, consider starting with a small allocation and review the company’s prospectus.
Start Date16-07-2021
End Date20-07-2021
Listing Date29-07-2021
Allotment Date26-07-2021
Current Price₹2,111.85
GMP₹1,110 (102.49%)
Lot Size13 Shares
Subscription0 Times
Face Value₹10 per share
Listing atNSE, BSE
Issue Price₹1073-₹1083
Pre Issue₹2,00,87,500
Post Issue₹2,21,65,062
Issue Size₹46,16,804
(aggregating up to 500.00 Cr)
(aggregating up to 500.00 Cr)
Fresh Issue₹20,77,562
(aggregating up to 225.00 Cr)
(aggregating up to 225.00 Cr)
Offer For Sale₹25,39,242
(aggregating up to 275.00 Cr)
(aggregating up to 275.00 Cr)
The Grey Market Premium (GMP) for Tatva Chintan Pharma Chem Limited is currently around ₹1,110 (102.49%). This indicates an estimated listing price of approximately ₹2,183 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
14 Apr 2025, 10:50 | ₹1,083 | ₹1,110 | ₹2,193 (102.49%) |
Financials overview In Lakhs
Here is a quick look at the recent financial performance of Tatva Chintan Pharma Chem Limited . The numbers below ( In Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
The IPO reservation for Tatva Chintan Pharma Chem Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
QIB | 38.46% | 23,08,401 |
Anchor | 23.08% | 13,85,040 |
NII (HNI) | 11.54% | 6,92,521 |
RETAIL | 26.92% | 16,15,882 |
TOTAL | 100.00% | 60,01,844 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 13 | ₹14,079 | |
sHNI | 15 | 195 | ₹2,11,185 | |
bHNI | 72 | 936 | ₹10,13,688 |
Below you can find the official contact details of Tatva Chintan Pharma Chem Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@tatvachintan.com
Phone: +91 75730 46951
Website: http://www.tatvachintan.com/
Address: Plot No. 502 / 17, GIDC Estate, Ankleshwar, Bharuch, Gujarat - 393002, India